MGO One Seven LLC Sells 234 Shares of HCA Healthcare, Inc. $HCA

MGO One Seven LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 16.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,175 shares of the company’s stock after selling 234 shares during the period. MGO One Seven LLC’s holdings in HCA Healthcare were worth $450,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Mitchell Sinkler & Starr PA bought a new position in shares of HCA Healthcare during the second quarter valued at about $215,000. CWM LLC increased its position in shares of HCA Healthcare by 5.4% during the second quarter. CWM LLC now owns 13,062 shares of the company’s stock valued at $5,004,000 after buying an additional 667 shares during the period. OFI Invest Asset Management increased its position in shares of HCA Healthcare by 9.4% during the second quarter. OFI Invest Asset Management now owns 63,826 shares of the company’s stock valued at $24,452,000 after buying an additional 5,483 shares during the period. Vanguard Personalized Indexing Management LLC increased its position in shares of HCA Healthcare by 22.0% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 38,771 shares of the company’s stock valued at $14,854,000 after buying an additional 6,997 shares during the period. Finally, Concurrent Investment Advisors LLC increased its position in shares of HCA Healthcare by 4.3% during the second quarter. Concurrent Investment Advisors LLC now owns 2,235 shares of the company’s stock valued at $856,000 after buying an additional 93 shares during the period. 62.73% of the stock is owned by institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

HCA has been the topic of several research analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $444.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 7th. Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. The Goldman Sachs Group started coverage on shares of HCA Healthcare in a report on Tuesday. They issued a “buy” rating and a $470.00 price objective on the stock. Barclays upped their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a report on Thursday, September 18th. Finally, Truist Financial set a $460.00 price objective on shares of HCA Healthcare in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $434.00.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $425.50 on Friday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The company has a market cap of $99.56 billion, a PE ratio of 17.89, a P/E/G ratio of 1.35 and a beta of 1.40. The firm’s 50 day moving average price is $410.05 and its 200-day moving average price is $378.42.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same period last year, the firm earned $5.50 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.